Disclosure of Directors and Officers Relevant Interests
|
|
Life Pharmacy Limited (LPL) | 10:00 am, Friday 3 October 2008 | LPL | 0.460 |
 0 |
(+0.00%) |
DISCLOSURE NOTICE
Disclosure of Directors and Officers Relevant Interests
(Section 19T, Securities Markets Act 1988)
A. Disclosure obligation (tick box to note which disclosure obligation applies)
Initial disclosure (complete Parts A, B, C, D, F, and G of this notice)
Ongoing disclosure (complete Parts A, B, C, E, F and G of this notice) x
B. Preliminary
1. Name Brian Philip Ingham
2. NZX company code of issuer LPL
Name of issuer Life Pharmacy Limited
3. Name of related body corporate (if applicable) N/A
4. Position you hold in the issuer Director
5. Date of this disclosure notice 30 September 2008
C. Nature of relevant interest
6. Name of registered holder(s) of security (as required by regulation 6A(b) or regulation 7(b)) Philip Ingham
7. Class and type of security (as required by regulation 6B or regulation 8) Ordinary Shares
8. Nature of relevant interest in security (as required by regulation 6A (a) or regulation 7(a)) beneficial interest
D. Date (for initial disclosure)
9. Date of disclosure obligation (as required by regulation 6C)
E. Transaction (for ongoing disclosure)
10. Date of last disclosure (as required by regulation 13)
11. Date(s) of acquisition(s) or disposal(s) (as required by regulation 9) 18 September 2008
12. Number of transactions (as required by regulation 12(2), if applicable) 1
13. Nature or type of transaction (as required by regulation 11(1)(a)) Issue of securities pursuant to a rights issue
14. Consideration (as required by regulation 10) $80,344.00
15. Number of securities held prior, set out by class and type (as required by regulation 8) 243,000 fully paid ordinary shares
16. Number of securities subject to acquisition or disposal (as required by regulation 11(1)(b)) 401,720 partly paid ordinary shares
F. Extent of relevant interest
17. Number of securities held now, set out by class and type (as required by regulation 6B or regulation 8) 243,000 fully paid ordinary shares; 401,720 partly paid ordinary shares
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of Directors and Officers Relevant Interests
(Section 19T, Securities Markets Act 1988)
A. Disclosure obligation (tick box to note which disclosure obligation applies)
Initial disclosure (complete Parts A, B, C, D, F, and G of this notice)
Ongoing disclosure (complete Parts A, B, C, E, F and G of this notice) x
B. Preliminary
1. Name Desmond Colin Flynn
2. NZX company code of issuer LPL
Name of issuer Life Pharmacy Limited
3. Name of related body corporate (if applicable) N/A
4. Position you hold in the issuer General Manager Strategic Business Development
5. Date of this disclosure notice 30 September 2008
C. Nature of relevant interest
6. Name of registered holder(s) of security (as required by regulation 6A(b) or regulation 7(b)) Desmond Colin Flynn
7. Class and type of security (as required by regulation 6B or regulation 8) Ordinary Shares
8. Nature of relevant interest in security (as required by regulation 6A (a) or regulation 7(a)) beneficial interest
D. Date (for initial disclosure)
9. Date of disclosure obligation (as required by regulation 6C)
E. Transaction (for ongoing disclosure)
10. Date of last disclosure (as required by regulation 13) 29 August 2008
11. Date(s) of acquisition(s) or disposal(s) (as required by regulation 9) 18 September 2008
12. Number of transactions (as required by regulation 12(2), if applicable) 1
13. Nature or type of transaction (as required by regulation 11(1)(a)) Issue of securities pursuant to a rights issue
14. Consideration (as required by regulation 10) $18,720.00
15. Number of securities held prior, set out by class and type (as required by regulation 8) 62,400 fully paid ordinary shares
16. Number of securities subject to acquisition or disposal (as required by regulation 11(1)(b)) 93,600 partly paid ordinary shares
F. Extent of relevant interest
17. Number of securities held now, set out by class and type (as required by regulation 6B or regulation 8) 62,400 fully paid ordinary shares; 93,600 partly paid ordinary shares
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of Directors and Officers Relevant Interests
(Section 19T, Securities Markets Act 1988)
A. Disclosure obligation (tick box to note which disclosure obligation applies)
Initial disclosure (complete Parts A, B, C, D, F, and G of this notice)
Ongoing disclosure (complete Parts A, B, C, E, F and G of this notice) x
B. Preliminary
1. Name Andrew John Davidson
2. NZX company code of issuer LPL
Name of issuer Life Pharmacy Limited
3. Name of related body corporate (if applicable) N/A
4. Position you hold in the issuer Director
5. Date of this disclosure notice 30 September 2008
C. Nature of relevant interest
6. Name of registered holder(s) of security (as required by regulation 6A(b) or regulation 7(b)) beneficial interest
7. Class and type of security (as required by regulation 6B or regulation 8) Ordinary Shares
8. Nature of relevant interest in security (as required by regulation 6A (a) or regulation 7(a)) beneficial interest
D. Date (for initial disclosure)
9. Date of disclosure obligation (as required by regulation 6C)
E. Transaction (for ongoing disclosure)
10. Date of last disclosure (as required by regulation 13) 25 Juy 2006
11. Date(s) of acquisition(s) or disposal(s) (as required by regulation 9) 18 September 2008
12. Number of transactions (as required by regulation 12(2), if applicable) 1
13. Nature or type of transaction (as required by regulation 11(1)(a)) Issue of securities pursuant to a rights issue
14. Consideration (as required by regulation 10) $31,200.00
15. Number of securities held prior, set out by class and type (as required by regulation 8) 104,000 fully paid ordinary shares
16. Number of securities subject to acquisition or disposal (as required by regulation 11(1)(b)) 156,000 partly paid ordinary shares
F. Extent of relevant interest
17. Number of securities held now, set out by class and type (as required by regulation 6B or regulation 8) 104,000 fully paid ordinary shares; 156,000 partly paid ordinary shares
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of Directors and Officers Relevant Interests
(Section 19T, Securities Markets Act 1988)
A. Disclosure obligation (tick box to note which disclosure obligation applies)
Initial disclosure (complete Parts A, B, C, D, F, and G of this notice)
Ongoing disclosure (complete Parts A, B, C, E, F and G of this notice) x
B. Preliminary
1. Name Mark Steven Vuksich
2. NZX company code of issuer LPL
Name of issuer Life Pharmacy Limited
3. Name of related body corporate (if applicable) N/A
4. Position you hold in the issuer Director
5. Date of this disclosure notice 30 September 2008
C. Nature of relevant interest
6. Name of registered holder(s) of security (as required by regulation 6A(b) or regulation 7(b)) MS Vuksich,FA Vuksich & WMG Yovich
7. Class and type of security (as required by regulation 6B or regulation 8) Ordinary Shares
8. Nature of relevant interest in security (as required by regulation 6A (a) or regulation 7(a)) beneficial interest
D. Date (for initial disclosure)
9. Date of disclosure obligation (as required by regulation 6C)
E. Transaction (for ongoing disclosure)
10. Date of last disclosure (as required by regulation 13) 2 November 2005
11. Date(s) of acquisition(s) or disposal(s) (as required by regulation 9) 18 September 2008
12. Number of transactions (as required by regulation 12(2), if applicable) 1
13. Nature or type of transaction (as required by regulation 11(1)(a)) Issue of securities pursuant to a rights issue
14. Consideration (as required by regulation 10) $2,000.00
15. Number of securities held prior, set out by class and type (as required by regulation 8) 904,978 fully paid ordinary shares
16. Number of securities subject to acquisition or disposal (as required by regulation 11(1)(b)) 10,000 partly paid ordinary shares
F. Extent of relevant interest
17. Number of securities held now, set out by class and type (as required by regulation 6B or regulation 8) 904,978 fully paid ordinary shares; 10,000 partly paid ordinary shares
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of Directors and Officers Relevant Interests
(Section 19T, Securities Markets Act 1988)
A. Disclosure obligation (tick box to note which disclosure obligation applies)
Initial disclosure (complete Parts A, B, C, D, F, and G of this notice)
Ongoing disclosure (complete Parts A, B, C, E, F and G of this notice) x
B. Preliminary
1. Name Elizabeth Mary Coutts
2. NZX company code of issuer LPL
Name of issuer Life Pharmacy Limited
3. Name of related body corporate (if applicable) N/A
4. Position you hold in the issuer Director
5. Date of this disclosure notice 30 September 2008
C. Nature of relevant interest
6. Name of registered holder(s) of security (as required by regulation 6A(b) or regulation 7(b)) Custodial Services Limited
7. Class and type of security (as required by regulation 6B or regulation 8) Ordinary Shares
8. Nature of relevant interest in security (as required by regulation 6A (a) or regulation 7(a)) beneficial interest
D. Date (for initial disclosure)
9. Date of disclosure obligation (as required by regulation 6C)
E. Transaction (for ongoing disclosure)
10. Date of last disclosure (as required by regulation 13) 17 July 2006
11. Date(s) of acquisition(s) or disposal(s) (as required by regulation 9) 18 September 2008
12. Number of transactions (as required by regulation 12(2), if applicable) 1
13. Nature or type of transaction (as required by regulation 11(1)(a)) Issue of securities pursuant to a rights issue
14. Consideration (as required by regulation 10) $9,200.00
15. Number of securities held prior, set out by class and type (as required by regulation 8) 104,000 fully paid ordinary shares
16. Number of securities subject to acquisition or disposal (as required by regulation 11(1)(b)) 46,000 partly paid ordinary shares
F. Extent of relevant interest
17. Number of securities held now, set out by class and type (as required by regulation 6B or regulation 8) 104,000 fully paid ordinary shares; 46,000 partly paid ordinary shares
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of Directors and Officers Relevant Interests
(Section 19T, Securities Markets Act 1988)
A. Disclosure obligation (tick box to note which disclosure obligation applies)
Initial disclosure (complete Parts A, B, C, D, F, and G of this notice)
Ongoing disclosure (complete Parts A, B, C, E, F and G of this notice) x
B. Preliminary
1. Name Wai-Yong Seet
2. NZX company code of issuer LPL
Name of issuer Life Pharmacy Limited
3. Name of related body corporate (if applicable) N/A
4. Position you hold in the issuer Merchandise Manager Health and Personal Care
5. Date of this disclosure notice 30 September 2008
C. Nature of relevant interest
6. Name of registered holder(s) of security (as required by regulation 6A(b) or regulation 7(b)) Wai Yong Seet
7. Class and type of security (as required by regulation 6B or regulation 8) Ordinary Shares
8. Nature of relevant interest in security (as required by regulation 6A (a) or regulation 7(a)) beneficial interest
D. Date (for initial disclosure)
9. Date of disclosure obligation (as required by regulation 6C)
E. Transaction (for ongoing disclosure)
10. Date of last disclosure (as required by regulation 13) 29 August 2008
11. Date(s) of acquisition(s) or disposal(s) (as required by regulation 9) 18 September 2008
12. Number of transactions (as required by regulation 12(2), if applicable) 1
13. Nature or type of transaction (as required by regulation 11(1)(a)) Issue of securities pursuant to a rights issue
14. Consideration (as required by regulation 10) $1,200.00
15. Number of securities held prior, set out by class and type (as required by regulation 8) 4,000 fully paid ordinary shares
16. Number of securities subject to acquisition or disposal (as required by regulation 11(1)(b)) 6,000 partly paid ordinary shares
F. Extent of relevant interest
17. Number of securities held now, set out by class and type (as required by regulation 6B or regulation 8) 4,000 fully paid ordinary shares; 6,000 partly paid ordinary shares
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of Directors and Officers Relevant Interests
(Section 19T, Securities Markets Act 1988)
A. Disclosure obligation (tick box to note which disclosure obligation applies)
Initial disclosure (complete Parts A, B, C, D, F, and G of this notice)
Ongoing disclosure (complete Parts A, B, C, E, F and G of this notice) x
B. Preliminary
1. Name John Andrew Bagnall
2. NZX company code of issuer LPL
Name of issuer Life Pharmacy Limited
3. Name of related body corporate (if applicable) N/A
4. Position you hold in the issuer Director
5. Date of this disclosure notice 30 September 2008
C. Nature of relevant interest
6. Name of registered holder(s) of security (as required by regulation 6A(b) or regulation 7(b)) LPL Trustee Limited
7. Class and type of security (as required by regulation 6B or regulation 8) Ordinary Shares
8. Nature of relevant interest in security (as required by regulation 6A (a) or regulation 7(a)) beneficial interest
D. Date (for initial disclosure)
9. Date of disclosure obligation (as required by regulation 6C)
E. Transaction (for ongoing disclosure)
10. Date of last disclosure (as required by regulation 13) 19 September 2008
11. Date(s) of acquisition(s) or disposal(s) (as required by regulation 9) 18 September 2008
12. Number of transactions (as required by regulation 12(2), if applicable) 1
13. Nature or type of transaction (as required by regulation 11(1)(a)) Issue of securities pursuant to a rights issue
14. Consideration (as required by regulation 10) $5,413,795.00
15. Number of securities held prior, set out by class and type (as required by regulation 8) 7,280,000 fully paid ordinary shares
16. Number of securities subject to acquisition or disposal (as required by regulation 11(1)(b)) 27,068,975 partly paid ordinary shares
F. Extent of relevant interest
17. Number of securities held now, set out by class and type (as required by regulation 6B or regulation 8) 7,280,000 fully paid ordinary shares; 27,068,975 partly paid ordinary shares
Signature (as required by regulation 14)
Related Attachments
Please login to My NZX to view the attachment(s) for this announcement